Valuation models
price $176.05 · as of Nov 2, 2026
DCF · Perpetuity growth · 5yused291.07 – 539.39385.1454% undervaluedDCF · Perpetuity growth · 10y306.84 – 564.61404.4856% undervaluedDCF · EBITDA exit · 5y549.74 – 609.13578.6270% undervaluedDCF · EBITDA exit · 10y517.48 – 626.95569.5369% undervaluedP/E · peers212.43 – 536.47278.7037% undervaluedP/E · own history223.17 – 356.27267.6234% undervaluedPEG—179.592% undervaluedEV/EBITDA · peers163.98 – 545.45179.802% undervaluedEV/Revenue · peers—50.06252% overvaluedEarnings power value115.31 – 221.07157.0812% overvaluedDividend discount15.16 – 33.1622.05698% overvaluedWall St. consensus target—183.004% belowCost of capital (WACC)—7.13%—
DCF · Perpetuity growth · 5y leads for mature & stable — positive operating income and three years of positive free cash flow. How the headline model is chosen.
Model value · DCF · Perpetuity growth · 5y
385.14
Universal Health Services closed at $176.05 — undervalued by 54% vs model.
291.07the model's range539.39
DCF · Perpetuity growth · 5y leads for mature & stable — positive operating income and three years of positive free cash flow. From a five-year discounted cash flow.
Other models
22.05 – 578.62
Wall St. target
183.00 4% below
Below model, 1y
30 of 30 days
How it is valued
Valued asMature & Stable
Moderate growth (~10% recent)Moderate margins (9% net margin)Highly cyclical earningsStrong FCF yield (9.3%)
Model estimates for research reference only, not investment advice. Every model rests on assumptions that may not match what happens; how each model works is in the manual.